JNJ250110C147000
- 0.01
- 0.000.00%
Johnson & Johnson Newsroom
Argus Research Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $185
Daiwa Adjusts Price Target on Johnson & Johnson to $150 From $170, Maintains Neutral Rating
Leerink Partners Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $169
Johnson & Johnson Price Target Maintained With a $181.00/Share by RBC Capital
Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $165
Johnson & Johnson Is Maintained at Neutral by B of A Securities
Johnson & Johnson Analyst Ratings
Wells Fargo Cuts Johnson & Johnson Price Target to $152 From $166, Maintains Equal Weight Rating
Stifel Nicolaus Adjusts Johnson & Johnson Price Target to $155 From $170, Maintains Hold Rating
A Quick Look at Today's Ratings for Johnson & Johnson(JNJ.US), With a Forecast Between $152 to $185
Goldman Sachs Adjusts Johnson & Johnson Price Target to $157 From $158, Maintains Neutral Rating
Morgan Stanley Cuts Price Target on Johnson & Johnson to $163 From $175, Keeps Equalweight Rating
RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $159
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $159
Barclays Adjusts Price Target on Johnson & Johnson to $159 From $160, Maintains Equalweight Rating
Johnson & Johnson Is Maintained at Neutral by B of A Securities
Johnson & Johnson Analyst Ratings
BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $160